
Eli Lilly to Release Early Data on Retatrutide Next-Generation Weight Loss Drug in 2025
Prime Highlights: Eli Lilly plans to release late-stage trial data for Retatrutide in 2025, ahead
Prime Highlights: Eli Lilly plans to release late-stage trial data for Retatrutide in 2025, ahead
Key highlights: Spotlight on emerging Technologies AI-driven Innovation with Dolffia Industry Whitepaper Release NTT DATA
Key Highlights: • $2.5 Million Grant to Expand Testing in Kenya • Significant Improvement in
Key Highlights: High Performance Infrared Imaging AI-powered Data Evaluation and Multi-modal imaging Versatile and customizable
Prime Highlights: Noel, who has been with UnitedHealthcare since 2007, previously led the Medicare and
Prime Highlights: The company’s stock rose significantly after promising results from an early-stage trial of
Prime Highlights: M42, the Middle East’s largest healthcare company, introduces a new operational structure to
Prime Highlights: The FDA has approved Johnson & Johnson’s Spravato (esketamine) nasal spray for standalone
Prime Highlights: Researchers led by 2024 Nobel Laureate David Baker develop AI-designed proteins that neutralize
Prime Highlights: Washington University research identifies a potential new use for an existing drug. RSK1
Prime Highlights: Medicare’s new $2,000 cap on out-of-pocket prescription drug costs could save patients thousands.
Prime Highlights: UnitedHealth reports Q4 earnings of $6.81 per share, exceeding estimates of $6.72. Health